An Open-Label Phase IV Study of the Efficacy of Bortezomib-based Combination Therapy the Treatment of Subjects With Multiple Myeloma
Latest Information Update: 04 May 2020
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide; Dexamethasone; Doxorubicin; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 03 May 2018 Planned End Date changed from 1 Oct 2018 to 1 Dec 2018.
- 03 May 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Oct 2018.
- 03 Oct 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.